Abstract
In a Perspective, David Bennett makes a case for neural reserve to be considered as a therapeutic endpoint in clinical trials for dementia.
MeSH terms
-
Alzheimer Disease / drug therapy*
-
Brain / physiology*
-
Cognitive Reserve*
-
Dementia / drug therapy*
-
Drug Discovery*
-
Humans